LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.98 | 17.25 | 771 | 445 | 1.7323 | 1.2486 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.98 | 17.25 | 3 | 445 | 0.0067 | -0.3114 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.98 | 17.25 | 990 | 445 | 2.2244 | 1.3718 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.98 | 17.25 | 969 | 445 | 2.1772 | 1.3610 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.95 | 17.25 | 820 | 471 | 1.7389 | 1.2458 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.95 | 17.25 | 7 | 471 | 0.0148 | -0.1722 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.95 | 17.25 | 1012 | 471 | 2.1460 | 1.3470 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.95 | 17.25 | 1000 | 471 | 2.1206 | 1.3412 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.91 | 17.25 | 825 | 494 | 1.6671 | 1.2227 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.91 | 17.25 | 15 | 494 | 0.0303 | -0.0285 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.91 | 17.25 | 1049 | 494 | 2.1198 | 1.3357 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.91 | 17.25 | 1026 | 494 | 2.0733 | 1.3250 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 14.88 | 17.25 | 854 | 534 | 1.5980 | 1.1985 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 14.88 | 17.25 | 16 | 534 | 0.0299 | -0.0151 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 14.88 | 17.25 | 1091 | 534 | 2.0414 | 1.3100 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 14.88 | 17.25 | 2 | 534 | 0.0037 | -0.3528 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 14.88 | 17.25 | 1074 | 534 | 2.0096 | 1.3026 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | C10 |